CALL US NOW (+9242)-35181549



Authors: SUHAIB AHMED, MOHAMMED SALEEM, BERNADETTE MODELL AND MARY PETROU [gview file=””] ABSTRACT Background We have investigated a strategy for identifying and counseling carriers of recessively inherited disorders in developing countries where consanguineous marriage is common. In such communities, gene variants are trapped within extended families, so that an affected

Read More

Informed choice in genetic screening for thalassaemia during pregnancy: audit from a national confidential inquiry

Authors: Darlison, Mary Petrou, John Old, Mark Layton and Lysandros Varnavides Bernadette Modell, Rodney Harris, Beverley Lane, Maren Khan, Matthew [gview file=””] Abstract Objective National audit of informed choice in antenatal screening for thalassaemia. Design Audit from the UK Confidential Enquiry into Counselling for Genetic Disorders. Setting Thalassaemia module of

Read More

Midwives’ perceptions of their role as facilitators of informed choice in antenatal screening

Authors: Shenaz Ahmed,BSc(Hons),PhD(Lecturer)a,n, LouiseD.Bryant,BSc(Hons),PhD(Lecturer)a, Phyllis Cole,RN,RM,DPSM(PublicHealthLeadforMaternity) [gview file=””] A b s t r a c t Objective: to explore midwives’perceptions oft heir role as facilitators of informed choice in antenatal screening. Design: qualitative. Setting: community midwives,Yorkshire and Humberregion,UK. Participants: community midwives offering antenatals creening(n¼15). Method: semi-structured interviews analysed using Thematic

Read More

Antenatal thalassaemia carrier testing: women’s perceptions of ‘information’ and ‘consent’

Authors: Shenaz Ahmed, Josephine Green, Jenny Hewison [gview file=””] Objectives: To explore the attitudes of a sample of pregnant women in the UK towards informed consent for antenatal thalassaemia carrier testing and perceived pre-test information needs for such testing. Setting: The study was conducted in two cities in the North

Read More

Premarital screening for b-thalassaemia in Southern Iran: options for improving the programme

Authors: Mehran Karimi, Nima Jamalian, HoomanYarmohammadi, Abdolrasoul Askarnejad, Abdolreza Afrasiabi and Alireza Hashemi [gview file=” Background b-thalassaemia is a preventable disease. Iran has about 20,000 homozygote b-thalassaemia patients and 3,750,000 carriers. Objective To assess the 10-year results of the screening programme, which has been operating in Southern Iran since 1995.

Read More